U.S. Government Awards Moderna $176 Million Bird Flu Vaccine Contract [zero hedge]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: zero hedge
U.S. Government Awards Moderna $176 Million Bird Flu Vaccine Contract Despite what can only be described as a host of looming unanswered questions about its mRNA technology and its Covid vaccines, the U.S has awarded Moderna a new $176 million contract to advance development of its bird flu vaccine. Stop us if you feel like you've seen this movie before... The U.S. government has granted Moderna $176 million to develop its bird flu vaccine amid rising concerns over the H5N1 virus outbreak in dairy cows and infections among dairy workers. The funds, provided by the Biomedical Advanced Research and Development Authority, will support the late-stage development and testing of an mRNA-based vaccine for H5N1 avian influenza, according to The Globe and Mail/Reuters . Moderna’s agreement with the government also includes options to prepare for future public health threats. The first outbreak in dairy cattle was reported in March, and the virus has since spread to over 130 herds in 12 states.
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the FirmGlobeNewswire
- MRNA Deadline: MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud LawsuitPR Newswire
- The Schall Law Firm Encourages Investor Participation In A Securities Fraud Case Against Moderna, Inc. Accesswire
- Faruqi & Faruqi Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 8, 2024 - MRNAPR Newswire
- IMPORTANT MRNA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNAGlobeNewswire
MRNA
Earnings
- 8/1/24 - Beat
MRNA
Sec Filings
- 10/4/24 - Form 4
- 10/4/24 - Form 3
- 10/2/24 - Form 8-K
- MRNA's page on the SEC website